Metabolic syndrome in psychiatric patients treated with antipsychotic drugs in Thailand

Clinical Psychopharmacology and Neuroscience

Volumn 8, Issue 2, 2010, Pages 79-83

  Udomratn, Pichet ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

Antipsychotics; Metabolic syndrome; Psychiatric patients; Thailand

Indexed keywords

NEUROLEPTIC AGENT;

ARTICLE; DIABETES MELLITUS; DIET; GENDER; HUMAN; HYPERTENSION; INCIDENCE; INFORMATION PROCESSING; MEDLINE; MENTAL PATIENT; METABOLIC SYNDROME X; PREVALENCE; THAILAND;

EID: 77956631616     PISSN: 17381088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Meyer JM, Stahl SM. The metabolic syndrome and schizophrenia. Acta Psychiatr Scand 2009;119:4-14.
2. Stahl SM, Mignon L, Meyer JM. Which comes first: atypical antipsychotic treatment or cardiometabolic risk? Acta Psychiatr Scand 2009;119:171-179.
3. Grundy SM. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am J Cardiol 1999;83:25F-29F.
4. Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC, et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999; 156:1686-1696. (Pubitemid 29517559)
5. Ananth J, Venkatesh R, Burgoyne K, Gadasalli R, Binford R, Gunathilake S. Atypical antipsychotic induced weight gain: pathophysiology and management. Ann Clin Psychiatry 2004;16:75-85.
6. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-689.
7. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005;112:3066-3072.
8. Saha S, Chant D, McGrath J. A systemic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry 2007;64:1123-1131.
9. Richter N, Juckel G, Assion HJ. Metabolic syndrome: a follow-up study of acute depressive inpatients. Eur Arch Psy-chiatry Clin Neurosci 2010;260:41-49.
10. Viinamäki H, Heiskanen T, Lehto SM, Niskanen L, Koivumaa-Honkanen H, Tolmunen T, et al. Association of depressive symptoms and metabolic syndrome in men. Acta Psychiatr Scand 2009;120:23-29.
11. Srisurapanont M, Likhitsathian S, Boonyanaruthee V, Charnsilp C, Jarusuraisin N. Metabolic syndrome in Thai schizophrenic patients: a naturalistic one-year follow-up study. BMC Psychiatry 2007;23:7-14.
12. Bai YM, Chen JY, Yang WS, Chi YC, Liou YJ, Lin CC, et al. Adinopectin as a potent biomarker for the metabolic syndrome in Chinese patients taking clozapine for schizophrenia. J Clin Pychiatry 2007;68:1834-1839.
13. Huang MC, Lu ML, Tsai CJ, Chen PY, Chiu CC, Jian DL, et al. Prevalence of metabolic syndrome among patients with schizophrenia or schizoaffective disorder in Taiwan. Acta Psychiatr Scand 2009;120:274-280.
14. Udomratn P, Vasiknanonte S. Pattern of prescribing antipsychotic drugs in Thailand. ASEAN J Psychiatry 2009;10:75-82.
15. Outkhanthawong S, Vasiknanonte S, Udomratn P. Second generation antipsychotics and metabolic syndrome. J Psychiatr Assoc Thailand 2007;52:216-232.
16. Danpakdee S. Prevalence of the metabolic syndrome in Thai schizophrenic patients receiving clozapine compared with patients receiving haloperidol. J Nakhon Ratchasima Rajanagarindra Psych Hosp 2008;8:34-43.
17. Tansupasiri P, Arunpongpaisal S, Pimpanit V, Khiewyoo J. The prevalence of metabolic syndrome in patients with schizophrenia at the psychiatric outpatient clinic, Srinagarind Hospital. J Psychiatr Assoc Thailand 2008;53:98-113.
18. Vasiknanonte S, Oukantawong S. Metabolic syndrome in antipsychotic treated psychiatric patients. J Psychiatr Assoc Thailand 2009;54:273-286.
19. Yoon YS, Lee ES, Park C, Lee S, Oh SW. The new definition of metabolic syndrome by the international diabetes federation is less likely to identify metabolically abnormal but non-obese individuals than the definition by the revised national cholesterol education program: the Korea NHANES study. Int J Obes 2007;31:528-534. (Pubitemid 46318623)
20. Boonyavarakul A, Choosaeng C, Supasyndh O, Panichkul S. Prevalence of the metabolic syndrome and its association factors between percentage body fat and body mass index in rural Thai population aged 35 years and older. J Med Assoc Thai 2005;88(Suppl 3):S121-S130.
21. Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am 2004;33:351-375.
22. Kato MM, Currier MB, Gomez CM, Hall L, Gonzalez-Blanco M. Prevalence of metabolic syndrome in Hispanic and non-Hispanic patients with schizophrenia. Prim Care Companion J Clin Psychiatry 2004;6:74-77.
23. Lamberti JS, Olson D, Crilly JF, Olivares T, Williams GC, Tu X, et al. Prevalence of the metabolic syndrome among patients receiving clozapine. Am J Psychiatry 2006;163:1273-1276.
24. Saddichha S, Manjunatha N, Ameen S, Akhtar S. Metabolic syndrome in first episode schizophrenia - a randomized double-blind controlled, short-term prospective study. Schizophr Res 2008;101:266-272.